Sexual Health & Testing

Doxy-PEP and STI Testing: What the CDC Guidance Says, and Why You Still Test

What the CDC says about doxy-PEP, who it is for, and why STI testing every 3 to 6 months still matters, including new gonorrhea data.

claude-cowork Oct 15, 2026 · 6 min read

Doxy-PEP is one of the biggest shifts in bacterial STI prevention in years, and it is easy to hear “a pill after sex” and assume testing matters less. The CDC guidance says the opposite: testing is part of the package.

Here is what the CDC actually says, what the newest research adds, and how to talk about it with a provider or a partner. It is general information, not medical advice.

What doxy-PEP is

Doxy-PEP stands for doxycycline post-exposure prophylaxis. It means taking doxycycline, an antibiotic, after sex to lower the chance of getting certain bacterial infections. In the CDC’s guidance the dose is 200 mg, taken as soon as possible and within 72 hours after oral, vaginal or anal sex, with no more than 200 mg in any 24 hours.

It is not the same thing as HIV PEP, which is a separate course of HIV medicine that a provider starts within 72 hours of a possible HIV exposure. Doxy-PEP is about three bacterial infections: syphilis, chlamydia and gonorrhea.

Who the CDC recommends it for

The CDC recommends that providers counsel gay, bisexual and other men who have sex with men, and transgender women, who have had at least one bacterial STI in the past 12 months, and offer doxy-PEP through shared decision-making. For people in those groups without a recent diagnosis who expect higher-risk sex, it says doxy-PEP can be discussed, though the trials did not directly study that group.

For everyone else, including cisgender women and cisgender heterosexual men, the CDC does not make a recommendation, because the evidence is not strong enough yet. A provider can still use clinical judgment for an individual patient.

Testing is part of the guidance

The CDC does not describe doxy-PEP as a replacement for screening. Its guidelines call for bacterial STI testing at the start and then every 3 to 6 months, at the body sites where exposure happens: nucleic acid amplification tests for gonorrhea and chlamydia, and blood tests for syphilis.

HIV screening continues on the schedule that fits the person’s HIV prevention plan, and the same visits are the place for hepatitis B and C screening and any vaccines a provider recommends. Each visit is also when a provider checks whether doxy-PEP is still the right fit.

What doxy-PEP does not cover

The guidance is limited to those three bacterial infections. It makes no claim about HIV, which is handled through PrEP, PEP and regular testing, and an antibiotic is not designed to act on viral infections such as herpes or HPV. Condoms, vaccines and testing all still do their own jobs.

Put the next test on the calendar

Protecht sets testing reminders on the schedule that fits you, so a 3 to 6 month check-in does not slip.

Set testing reminders

What the newest research adds

In May 2026, The Lancet Infectious Diseases published a study from Kaiser Permanente Southern California and UC Berkeley. It looked at health records for more than 26,000 men who have sex with men and transgender women who were living with HIV or using HIV prevention medicine.

Doxy-PEP kept lowering chlamydia (by about two-thirds) and syphilis (by more than half), and the protection was still visible more than two years later. Gonorrhea was different. An early drop of more than 40 percent faded to no measurable benefit by 2025, as strains resistant to tetracycline-type antibiotics became more common.

It is an observational study, so it shows an association rather than proving cause, and the authors say prevention should be tailored to each infection while resistance is watched closely. The CDC’s own page says the long-term effects on antimicrobial resistance are not yet known and that it will keep monitoring and update its guidelines as new data arrive.

Why a recent result still matters

On doxy-PEP, the point of testing is the same as always: find an infection early, get treated, and let partners know. The gonorrhea numbers are a good example of why a prevention tool alone is not the whole picture, because how well it works can change over time.

A result is also a snapshot. Our post on what the date on a result tells you explains why a negative describes the day the sample was taken, not the days after.

Questions worth asking your provider

Does the CDC guidance fit my situation? How often should I be tested for each infection while I take it? Which body sites will be swabbed? How does this fit with my PrEP schedule, if I use PrEP? What should I do if I notice a symptom between visits? Doxycycline can also cause side effects such as sun sensitivity and stomach upset, so it is worth asking what to expect.

Sharing your status when you use doxy-PEP

Doxy-PEP does not change how a partner should read a result. “Tested on [date], negative for these infections, next test on [date]” is still the line that does the work. A dated result that comes from a provider, rather than a screenshot, lets the other person see what was tested and when.